DGAP-News: PharmaSGP-Gruppe schließt Erwerb des OTC-Ma

DGAP-News: PharmaSGP-Gruppe schließt Erwerb des OTC-Markenportfolios (Baldriparan(R), Formigran(R), Spalt(R) und Kamol(R)) von GSK ab

DGAP-News: PharmaSGP-Gruppe schließt Erwerb des OTC-Markenportfolios (Baldriparan(R), Formigran(R), Spalt(R) und Kamol(R)) von GSK ab

boersennews.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from boersennews.de Daily Mail and Mail on Sunday newspapers.

Related Keywords

Germany , Grafelfing , Bayern , Hungary , Munich , Belgium , Italy , Czech Republic , Austria , Poland , Spain , Switzerland , France , German , , Glaxosmithkline Group , S Distribution Services , Group It , Business Development , Her Business , New Market , Appreciation Potential , Growth Strategy , Years Market , Target Markets , The Future , Growth Path , Areas Insomnia , Pain Management , European Platform , Earnings Forecast , Contact Curled Phone , Distribution Channel Pharmacy , Active Ingredients , Side Effects , Coming Germany , Market Leader , Product Portfolio , Her Business Model , European Countries , Eastern Europe , John Million , Ebit Margin , Some Her Competitive Position , Her Product Offering , European Occupancy , Her Growth Strategy , Financial Object , Reporting Obligations , Press Releases , Media Archive , German Take , Regulated Market , Free Traffic ,